We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
ISL
401
Ingalls & Snyder LLC
New York
$24.8M -$200K -2,240 -0.8%
TNB
402
Thomasville National Bank
Georgia
$24.8M +$160K +1,787 +0.6%
CCM
403
Covington Capital Management
California
$24.8M +$203K +2,269 +0.8%
GT
404
Glenview Trust
Kentucky
$24.8M +$1.07M +11,984 +4%
FDCDDQ
405
Federation des caisses Desjardins du Quebec
Quebec, Canada
$24.5M +$1.01M +11,363 +4%
KAS
406
Kestra Advisory Services
Texas
$24.4M +$1.6M +17,935 +7%
BBHC
407
Brown Brothers Harriman & Co
New York
$24.2M -$1.63M -18,289 -6%
WB
408
WesBanco Bank
West Virginia
$24.2M -$12.2M -136,877 -33%
CNAM
409
Campbell Newman Asset Management
Wisconsin
$23.8M -$177K -1,984 -0.7%
SEM
410
Suncoast Equity Management
Florida
$23.5M -$1.65M -18,507 -6%
Two Sigma Investments
411
Two Sigma Investments
New York
$23.3M +$20.3M +227,665 +524%
VI
412
Vestcor Inc
New Brunswick, Canada
$23.3M +$366K +4,098 +2%
TRCT
413
Tower Research Capital (TRC)
New York
$22.9M +$7.59M +84,998 +47%
PFPT
414
Pinnacle Financial Partners (Tennessee)
Tennessee
$22.5M +$2.21M +24,768 +10%
VLKIM
415
Van Lanschot Kempen Investment Management
Netherlands
$22.4M -$4.14M -46,426 -15%
CT
416
Cambridge Trust
Massachusetts
$22.3M +$1.16M +12,945 +5%
WIC
417
Willis Investment Counsel
Georgia
$22.2M -$3.28M -36,755 -12%
CA
418
Cornerstone Advisors
North Carolina
$22.2M +$2.68M +30,000 +13%
HIMCH
419
Hartford Investment Management Co (HIMCO)
Connecticut
$22.2M +$175K +1,956 +0.8%
AWS
420
Atria Wealth Solutions
New York
$22.2M +$1.32M +14,828 +6%
EB
421
Eastern Bank
Massachusetts
$21.9M +$294K +3,297 +1%
SGA
422
Sector Gamma AS
Norway
$21.8M -$14.4M -161,179 -39%
RPAM
423
Rhenman & Partners Asset Management
Sweden
$21.8M -$4.46M -50,000 -19%
BCIM
424
British Columbia Investment Management
British Columbia, Canada
$21.6M -$3.84M -43,041 -15%
RS
425
Robeco Schweiz
Switzerland
$21.3M +$42.2K +473 +0.2%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.